Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years (2023)
Source: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF
Subjects: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA
ABNT
VASSILIADES, Sandra Valeria; NAVARAUSCKAS, Vitor Bastos; DIAS, Marcio Vinicius Bertacine; PARISE FILHO, Roberto. Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, Bucharest, v. 13, n. 1 p. 1-20 art. 79, 2023. Disponível em: < https://dx.doi.org/10.33263/BRIAC131.079 > DOI: 10.33263/BRIAC131.079.APA
Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079NLM
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):Available from: https://dx.doi.org/10.33263/BRIAC131.079Vancouver
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):Available from: https://dx.doi.org/10.33263/BRIAC131.079